Literature DB >> 2320566

Expression of recombinant glutathione S-transferase pi, Ya, or Yb1 confers resistance to alkylating agents.

R B Puchalski1, W E Fahl.   

Abstract

Increased levels of glutathione S-transferase (GST; RX:glutathione R-transferase; EC 2.5.1.18) mRNA, protein, and activity in tumor biopsy samples and in drug-resistant cultured cells are associated with resistance to anticancer drugs. We report that each of three full-length cloned GST cDNAs, that for pi (acidic), Ya (basic), and Yb1 (neutral), can confer drug resistance when expressed in cultured mammalian cells. In one approach, stably transfected mouse C3H/10T1/2 cells that express GST pi, Ya, or Yb1 were cloned and analyzed for drug resistance in colony-forming assays. Transiently transfected COS cells that were sorted on a fluorescence-activated cell sorter were used in the second approach to avoid interclonal variation in factors other than the recombinant GST and to show that reversion of transient GST expression correlated with loss of drug resistance. A sorting technique, developed to separate the 20% of the electroporated COS cell population that transiently expressed GST pi, Ya, or Yb1 from the nonexpressing population, was based on a GST-catalyzed intracellular conjugation of glutathione to the fluorescent labeling reagent monochlorobimane. GST Ya conferred the greatest increase in resistance to chlorambucil and melphalan (1.3- to 2.9-fold), Yb1 conferred the greatest increase in resistance to cisplatin (1.5-fold), and pi conferred the greatest increase in resistance to a racemic mixture of 7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a] pyrene and 7 alpha,8 beta-dihydroxy-9 beta,10 beta-epoxy-7,8,9,10-tetrahydrobenzo [a]pyrene and doxorubicin (1.5- and 1.3-fold) relative to controls. These resistance values to alkylating agents are commensurate with values observed clinically. Cytotoxicity curves representing recombinant GST+ populations were significantly different from their controls with P values ranging from 0.005 to 0.0001. No resistance to vinblastine was detected. Conferred drug resistance was proportional to the magnitude of GST Ya expression, and reversion of transient expression in GST Ya+ COS cell clones to a GST Ya- phenotype was associated with total loss of drug resistance.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2320566      PMCID: PMC53705          DOI: 10.1073/pnas.87.7.2443

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

Review 1.  Glutathione S-transferases: gene structure, regulation, and biological function.

Authors:  C B Pickett; A Y Lu
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

2.  Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient.

Authors:  C R Wolf; I P Hayward; S S Lawrie; K Buckton; M A McIntyre; D J Adams; A D Lewis; A R Scott; J F Smyth
Journal:  Int J Cancer       Date:  1987-06-15       Impact factor: 7.396

3.  Glutathione S-transferases. The first enzymatic step in mercapturic acid formation.

Authors:  W H Habig; M J Pabst; W B Jakoby
Journal:  J Biol Chem       Date:  1974-11-25       Impact factor: 5.157

4.  Monobromobimane: a substrate for the fluorimetric assay of glutathione transferase.

Authors:  P B Hulbert; S I Yakubu
Journal:  J Pharm Pharmacol       Date:  1983-06       Impact factor: 3.765

5.  Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine.

Authors:  O W Griffith
Journal:  Anal Biochem       Date:  1980-07-15       Impact factor: 3.365

6.  Promoter-glutathione S-transferase Ya cDNA hybrid genes. Expression and conferred resistance to an alkylating molecule in mammalian cells.

Authors:  T H Manoharan; R B Puchalski; J A Burgess; C B Pickett; W E Fahl
Journal:  J Biol Chem       Date:  1987-03-15       Impact factor: 5.157

7.  High-dose cyclophosphamide. An effective treatment for advanced refractory multiple myeloma.

Authors:  R E Lenhard; M M Oken; J M Barnes; R L Humphrey; J H Glick; M N Silverstein
Journal:  Cancer       Date:  1984-04-01       Impact factor: 6.860

8.  Inhibition of soluble glutathione S-transferase by diuretic drugs.

Authors:  J T Ahokas; C Davies; P J Ravenscroft; B T Emmerson
Journal:  Biochem Pharmacol       Date:  1984-06-15       Impact factor: 5.858

9.  Glutathione S-transferases in nitrogen mustard-resistant and -sensitive cell lines.

Authors:  A L Buller; M L Clapper; K D Tew
Journal:  Mol Pharmacol       Date:  1987-06       Impact factor: 4.436

10.  Glutathione conjugation of the carcinogenic and mutagenic electrophile (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-oxy-7,8,9,10-tetra hydrobenzo[a]pyrene catalyzed by purified rat liver glutathione transferases.

Authors:  B Jernström; M Martinez; D J Meyer; B Ketterer
Journal:  Carcinogenesis       Date:  1985-01       Impact factor: 4.944

View more
  33 in total

1.  Overexpression of the regulatory subunit of gamma-glutamylcysteine synthetase in HeLa cells increases gamma-glutamylcysteine synthetase activity and confers drug resistance.

Authors:  S R Tipnis; D G Blake; A G Shepherd; L I McLellan
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

2.  Transcriptional and post-transcriptional mechanisms can regulate cell-specific expression of the human Pi-class glutathione S-transferase gene.

Authors:  G J Moffat; A W McLaren; C R Wolf
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

3.  Functional antioxidant responsive elements.

Authors:  W W Wasserman; W E Fahl
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

4.  Genomic cloning and characterization of the rat glutathione S-transferase-A3-subunit gene.

Authors:  N Fotouhi-Ardakani; G Batist
Journal:  Biochem J       Date:  1999-05-01       Impact factor: 3.857

Review 5.  Adhesion molecules in host defense.

Authors:  A Etzioni
Journal:  Clin Diagn Lab Immunol       Date:  1994-01

6.  Co-variation of glutathione transferase expression and cytostatic drug resistance in HeLa cells: establishment of class Mu glutathione transferase M3-3 as the dominating isoenzyme.

Authors:  X Y Hao; M Widersten; M Ridderström; U Hellman; B Mannervik
Journal:  Biochem J       Date:  1994-01-01       Impact factor: 3.857

7.  Molecular cloning and heterologous expression of a cDNA encoding a mouse glutathione S-transferase Yc subunit possessing high catalytic activity for aflatoxin B1-8,9-epoxide.

Authors:  J D Hayes; D J Judah; G E Neal; T Nguyen
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

8.  Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport.

Authors:  M Müller; C Meijer; G J Zaman; P Borst; R J Scheper; N H Mulder; E G de Vries; P L Jansen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

9.  Rapid detection of inducers of enzymes that protect against carcinogens.

Authors:  H J Prochaska; A B Santamaria; P Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

10.  Human osteosarcoma xenografts and their sensitivity to chemotherapy.

Authors:  Skjalg Bruheim; Oyvind S Bruland; Knut Breistol; Gunhild M Maelandsmo; Oystein Fodstad
Journal:  Pathol Oncol Res       Date:  2004-09-25       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.